DMRA
$21.96+3.29%
Damora Therapeutics Inc.Stock · HealthcareRussell 2000 · 0.04% of IWMNasdaq Composite · 0.004% of ONEQRussell 3000 · 0.002% of IWV
DMRA — Damora Therapeutics Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEEEEEEEEEESEEEEEEE
50.0100.0150.0200.0250.0300.0350.0400.0050.0M$21.96—20202022202320252026
2026-10-27
Price$21.96
MA20$26.02
MA50$25.93
Vol286.1K
Key stats#
Price data
- Price
- $21.96
- YTD price return
- -4.56%
- YTD total return
- -4.56%
- Next earnings
- Nov 5, 2026
- Market cap
- 1.4B
- Enterprise value
- 815.3M
- Shares outstanding
- 61.7M
- 52W low
- $4.95
- 52W high
- $38.33
- From 52W high
- -42.70%
- From 52W low
- +343.64%
- 52W range
- 51%
Volume
- Rel volume
- 0.43×
- 30D volume
- 663.1K
- 30D $ vol
- 14M
Fundamentals
- EPS (ttm)
- -$10.70
- Book value/share
- $8.36
- ROE
- -50.93%
- ROA
- -48.35%
- Current ratio
- 19.73
Growth (CAGR, ttm) · 10Y
- Shares
- +4573.11%+284.56%+127.64%n/a
Per-share growth (CAGR, ttm) · 10Y
- Book value/share
- +1.09%-40.80%-43.09%n/a
- Price
- +199.20%+18.04%-23.31%n/a
- Total return
- +199.20%+18.04%-23.31%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -2.1×
- Fwd P/E
- -9.6×
- P/B (mrq)
- 2.6×
- Buyback yield (realized, 1y)
- -4573.11%
- Shareholder yield (realized, 1y)
- -4573.11%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/B
- 86th
Bar = where today’s multiple sits in DMRA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
+3.29%
5D
+6.24%
1M
+6.29%
3M
-25.41%
YTD
-4.56%
1Y
+198.98%
5Y
-73.46%
Financial statements
Open full DMRA financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
